Page last updated: 2024-10-31

mitoxantrone and Autosomal Chromosome Disorders

mitoxantrone has been researched along with Autosomal Chromosome Disorders in 2 studies

Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Doi, T1
Sakamaki, S1
Koike, K1
Matsunaga, T1
Kobayashi, D1
Muramatsu, H1
Sato, T1
Watanabe, N1
Kougo, Y1
Niitsu, Y1
Schiller, G1
Gajewski, J1
Territo, M1
Nimer, S1
Lee, M1
Belin, T1
Champlin, R1

Trials

1 trial available for mitoxantrone and Autosomal Chromosome Disorders

ArticleYear
Long-term outcome of high-dose cytarabine-based consolidation chemotherapy for adults with acute myelogenous leukemia.
    Blood, 1992, Dec-15, Volume: 80, Issue:12

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Chromosome Disorders;

1992

Other Studies

1 other study available for mitoxantrone and Autosomal Chromosome Disorders

ArticleYear
[CD7, HLA-DR, CD38 positive acute undifferentiated leukemia with subcutaneous tumor and thymoma].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1996, Volume: 37, Issue:8

    Topics: Acute Disease; ADP-ribosyl Cyclase; ADP-ribosyl Cyclase 1; Antigens, CD; Antigens, CD7; Antigens, Di

1996